Find latest Skin videos · 400+ videos
Insights from 2023 Society for Melanoma Research Annual Meeting
Y

2023 SMR Congress Insights: "Time-to-Event Machine Learning Prediction of Metastatic Recurrence From Early Stage Melanoma"

By Insights from 2023 Society for Melanoma Research Annual Meeting FEATURING Yevgeniy Semenov
By Insights from 2023 Society for Melanoma Research Annual Meeting FEATURING Yevgeniy Semenov
60 views
November 24, 2023
Read more about this here:
"Development and validation of time-to-event models to predict metastatic recurrence of localized cutaneous melanoma"
"Prediction of early-stage melanoma recurrence using clinical and histopathologic features"
Comments 0
Login to view comments. Click here to Login

Related Videos

22:58

The Role of Adjuvant IO vs. Targeted Therapy for BRAF V600-Mutant St…

Tarek Haykal

802 views
24:14

Advances in the Treatment of Melanoma

Masterclasses in Dermatology

D. Fisher

833 views
12:46

FDA Approval of Lifileucel for Unresectable or Metastatic Melanoma: …

Stanford Medicine

A. Betof Warner

1.0K views
24:27

ASCO® 2024 Summary: "Highlights in Melanoma - Neoadjuvant and Adjuva…

2024 ASCO® Annual Meeting Insights Hub

Z. Eroglu

340 views
03:55

ASCO® 2024 Insights: "COMBI-AD Study - Dabrafenib + Trametinib in St…

2024 ASCO® Annual Meeting Insights Hub

A. Hauschild

533 views
08:41

ASCO® 2024 Insights: "NADINA Trial - Neoadjuvant Nivo + Ipi in Macro…

2024 ASCO® Annual Meeting Insights Hub

C. Blank

293 views
07:23

Long-Term Side Effects Associated With IO Treatment vs. TT in Adjuva…

Mees Egeler

330 views
16:05

Adjuvant and Neoadjuvant Advances in Stage 3 Melanoma: Insights From…

Penn Medicine Abramson Cancer Center

T. Mitchell

66 views
14:23

Advantages & Disadvantages of Adjuvant IO vs. Targeted Treatment for…

Alexander van Akkooi

403 views
10:40

ESMO 2024 Insights: Survival Impact of Adjuvant Treatment in Stage I…

2024 ESMO Annual Meeting Insights Hub

H. Helgadottir

120 views
05:43

Neoadjuvant Cobimetinib + Atezolizumab ± Vemurafenib for High-Risk O…

Tina Hieken

32 views
07:45

Melanoma Treatment Updates: NADINA Trial and Toxicity Management

Christian Blank

38 views
14:01

ASCO® 2024 Insights: "Macroscopic Stage III Melanoma and Immunothera…

2024 ASCO® Annual Meeting Insights Hub

H. Kluger

131 views
52:19

2024 Updates on Neoadjuvant Therapy for Resectable Melanoma

Winship Melanoma and Cutaneous Oncology Symposium

S. Patel

298 views
26:24

Case-Based Panel Discussion: Managing Immune-Related Hepatitis in St…

The Immuno-Oncology Clinical Network (IOCN)

A. Olsson-Brown, A. Johnson, T. Guinan, B. O'Carrigan, C. Barlow

35 views
40:00

ASCO® 2024: Highlights and Analysis of Key Solid Cancer Trials

ecancer

B. Gyawali

105 views
16:14

Highlights From the Recent Melanoma Research Alliance Meeting: What'…

Kim Margolin

165 views
10:42

ESMO 2024 Insights: Distant Metastasis-Free Survival in Neoadjuvant …

2024 ESMO Annual Meeting Insights Hub

A. van Akkooi

23 views
02:57

ASCO® 2024 Insights: "NADINA Trial - Neoadjuvant Nivo + Ipi vs. Adju…

ecancer

C. Blank

52 views
46:28

2024 Melanoma Update: Insights Into Sentinel Node Evaluation

Scripps Health

M. Ross

133 views
AUTOPLAY